Skip to content
Screener

Bio-Techne Corp. TECH Q1 2026 earnings

Reported November 5, 2025 · Before market open

Revenue$286.6MMiss by $4.8M
EPS$0.42Miss by $0.00
Revenue estimate$291.3M
EPS estimate$0.42

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$292.4M
EPS estimate$0.46

Financials

Q1 2026

Income statement

See full
Revenue$286.6M-1.0%
Gross profit$188.1M+2.8%
Operating income$47.7M+19.2%
Net income$38.2M+13.6%
EPS (diluted)$0.24+14.3%

Balance sheet

See full
Cash & equivalents$145.0M-22.7%
Total debt$394.5M-1.1%
Total assets$2.5B-7.7%

Cash flow

See full
Operating cash flow$27.6M-56.8%
CapEx$5.4M-41.5%
Free cash flow$22.2M-59.4%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$8.66B-31.4%
Enterprise value$8.91B-30.5%
P/S7.1×-3.7×

Profitability

See full
Gross margin65.4%-0.1pp
FCF margin18.4%-2.5pp

Returns & leverage

See full
Current ratio4.2×-0.3×

Segments

By product

See full
Consumables$231.6M+0.3%
Service$27.5M+0.5%
Instruments$21.8M-16.7%
Royalty$5.6M+11.8%

By segment

See full
Protein Sciences$202.2M-1.1%
Diagnostics And Spatial Biology$79.5M-4.5%

FAQ

When did Bio-Techne Corp. report Q1 2026 earnings?
Bio-Techne Corp. (TECH) reported Q1 2026 earnings on November 5, 2025 before market open.
What were Bio-Techne Corp.'s Q1 2026 revenue and EPS?
Bio-Techne Corp. reported revenue of $286.6M and eps of $0.42 for Q1 2026.
Did Bio-Techne Corp. beat estimates in Q1 2026?
Revenue missed the consensus estimate of $291.3M by $4.8M. EPS missed the consensus estimate of $0.42 by $0.00.
How did Bio-Techne Corp.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 1.0% from $289.5M a year earlier and eps grew 0.0% from $0.42.
Where can I find Bio-Techne Corp.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001104659-25-106631) and the 10-Q periodic report (0001104659-25-107053) directly on SEC EDGAR. The filing index links above go to sec.gov.